Skip to main content
. 2023 Jan 14;13:100116. doi: 10.1016/j.ynpai.2023.100116

Table 4.

Effect of a single administration (2 µg/rat i.t.) of compound 8 in ALGOGram.a

Pain area Model (test) Compound 8
Internal reference
Percentage of analgesic activity vs vehicle Reference ID Percentage of activity vs vehicle
Acute and tonic pain Healthy rats (paw pressure test) −5.5 % Morphine, 4 mg/kg s.c., T30 min 67 %
Healthy rats (tail flick test) 0.5 % Morphine, 4 mg/kg s.c., T30 min 66 %
Acetic acid test (abdominal cramps) 24.5 % (-) U50, 488H, 4 mg/kg s.c., T30 min 100 %
Formalin test (paw licking time early phase) 31.5 % Morphine, 4 mg/kg s.c., T30 min 65 %
Formalin test (paw licking time late phase) 45.5 % Morphine, 4 mg/kg s.c., T30 min 77 %



Neuropathic pain Bennett model (Paw pressure test) −20 % Morphine, 3 mg/kg s.c., T30 min 188 %
Oxaliplatin (paw immersion test) −2% Duloxetine
100 mg/kg, p.o., T60 min
66 %



Inflammatory pain Carrageenan (paw pressure test) 2 % Indomethacin 30 mg/kg, p.o., T60 min 92 %
Kaolin (Gait score) −13 % Indomethacin 30 mg/kg, p.o., T60 min 64 %



Post-operative pain Brennan model (Electronic Von Frey test) 11 % Morphine, 4 mg/kg s.c., T30 min 107 %



Visceral pain TNBS (colonic distension) 6.5 % (_) U50, 488H, 4 mg/kg s.c., T30 min 168 %
a

Testing: 120 min after treatment. n = 4/model/test. Results are expressed for each group as percentage of activity calculated from the mean value of the vehicle-treated animals and compared to naïve animals, control paw or cut-off value depending on the test (from the ANS Biotech historical database (Darbaky et al., 2017, Gris et al., 2016, Silos-Santiago et al., 2013). All experiments were done in a blinded manner.